T Cell Receptor Alpha Joining 4: A Potential Drug Target (G28751)

Target Name: TRAJ4

NCBI ID: G28751

TRAJ4

Other Name(s): T cell receptor alpha joining 4

T Cell Receptor Alpha Joining 4: A Potential Drug Target

T cell receptor alpha joining 4 (TRAJ4) is a protein that plays a crucial role in the immune system. It is a type of protein known as a co-receptor, which means it is found in the same family of proteins that are used by the T cells to recognize and respond to different types of molecules in the body.

The T cell receptor alpha joining 4 is a protein that is found in the ITCH (intercellular signaling conductance) signaling pathway. This pathway is a critical part of the immune system, as it helps to regulate the movement and activity of T cells.

One of the things that makes the T cell receptor alpha joining 4 protein so important is its role in the immune response to viruses and other types of malware. When a T cell encounters a virus or other type of malware, it needs to be able to recognize and respond to it in a timely manner in order to protect the body from infection.

The T cell receptor alpha joining 4 protein helps to facilitate this response by allowing T cells to recognize and respond to different types of molecules that are present in the body. It does this by helping to regulate the movement of T cells along the body's surface, which is critical for their ability to interact with different types of molecules.

In addition to its role in the immune response, the T cell receptor alpha joining 4 protein is also thought to be a potential drug target. This is because it is a protein that is involved in many different processes in the body, and many researchers believe that it may be possible to use it as a target for new drugs.

One of the reasons why the T cell receptor alpha joining 4 protein is thought to be a good candidate for a drug target is because it is involved in a number of different processes that are important for the body's overall health. For example, it is involved in the regulation of cell growth and differentiation, and it is also involved in the regulation of the immune system.

In addition to its role in the immune system, the T cell receptor alpha joining 4 protein is also thought to be involved in the regulation of cell death. This is important because many diseases, such as cancer, are caused by the destruction of cells that have become damaged or dysfunctional.

Overall, the T cell receptor alpha joining 4 protein is a protein that is involved in many important processes in the body. As a result, it is a potential drug target that could be used to treat a wide range of diseases.

Protein Name: T Cell Receptor Alpha Joining 4

The "TRAJ4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRAJ4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets